1. No significant association of type 2 diabetes-related genetic risk scores with glycated haemoglobin levels after initiating metformin or sulphonylurea derivatives

   Martono, D. P., Heerspink, H. J. L., Hak, E., Denig, P. & Wilffert, B., 5-Jun-2019, In : Diabetes obesity & metabolism. 7 p.

   Research output: Contribution to journal › Article › Academic › peer-review

2. Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients

   Wang, Y., Bahar, M. A., Jansen, A., Kocks, J. W. H., Alffenaar, J., Hak, E., Wilffert, B. & Borgsteede, S. D., 24-May-2019, In : Journal of Antimicrobial Chemotherapy. 17 p., dkz221.

   Research output: Contribution to journal › Article › Academic › peer-review

3. A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia

   Osmanova, D. Z., Freidin, M. B., Fedorenko, O. Y., Pozhidaev, I. V., Boiko, A. S., Vyalova, N. M., Tiguntsev, V. V., Kornetova, E. G., Loonen, A. J. M., Semke, A. V., Wilffert, B., Bokhan, N. A. & Ivanova, S. A., 9-Apr-2019, In : BMC MEDICAL GENETICS. 20, Suppl 1, p. 47

   Research output: Contribution to journal › Article › Academic › peer-review

4. Sekseverschillen in gemelde bijwerkingen van SSRI’s

   Wilffert, B., 27-Dec-2018, In : Nederlands Platform voor Farmaceutisch Onderzoek. p. e1674 1 p., 3.

   Research output: Contribution to journal › Article › Professional

5. Effect of Roux-en-Y gastric bypass on the bioavailability of metoprolol from immediate and controlled release tablets: A single oral dose study before and after surgery

   Yska, J. P., Wanders, J. T. M., Odigie, B., Apers, J. A., Emous, M., Totté, E. R. E., Boerma, E. C., Ubels, F. L., Woerdenbag, H. J., Frijlink, H. W., Wilffert, B. & Van Roon, E. N., 16-Mar-2019, In : European Journal of Hospital Pharmacy: Science and Practice.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (343) »

1. Meest Innovatieve geneesmiddelen. Medicatie voor borstkanker, spierziekte en reuma ‘bekroond’

   Bob Wilffert

   22/12/2017

   1 media contribution

   Press/Media: Expert Comment › Popular

View all (1) »

1. Implementation of Pharmacogenetics in Clinical Practice.

   Berend Wilffert (Invited speaker)

   23-Aug-2018 → 24-Aug-2018

   Activity: Talk or presentation › Professional

2. Implementation of Pharmacogenetics in Clinical Practice.

   Berend Wilffert (Invited speaker)

   23-Aug-2018 → 25-Aug-2018

   Activity: Talk or presentation › Professional

3. Implementation of Pharmacogenetics in Pharmacotherapy of Chronic Diseases.

   Berend Wilffert (Invited speaker)

   10-Aug-2018 → 11-Aug-2018

   Activity: Talk or presentation › Professional

View all (8) »

1. Poster Prize

   Bob Wilffert (Recipient), 2015

   Prize › Academic

2. Naunyn-Schmiedeberg-Preis für Pharmakologie

   Bob Wilffert (Recipient), 2011

   Prize › Academic

View all (2) »